Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Details for Australian Patent Application No. 2005202046 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Heithecker, Renate; Hilman, Jurgen; Lipp, Ralph; Heil, Wolfgang

Agent Davies Collison Cave

Pub. Number AU-B-2005202046

Parent 780330

Filing date 13 May 2005

Wipo publication date 9 June 2005

Acceptance publication date 20 November 2008

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/585 (2006.01)

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

Event Publications

26 May 2005 Complete Application Filed

9 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202046

10 April 2008 Alteration of Name

  The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft

20 November 2008 Application Accepted

  Published as AU-B-2005202046

19 March 2009 Standard Patent Sealed

25 August 2011 Alteration of Name

  The name of the patentee has been altered to Bayer Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202047-Improvements in or relating to Fastening Systems

2005202045-A Training Device